Loading organizations...
Key people at Legemiddelindustrien.
Legemiddelindustrien (LMI) is a Norwegian industry association representing the pharmaceutical and life science sectors. It provides essential services like industry information, education, and advocacy to its member companies. LMI’s work focuses on research and development, clinical studies, drug production, health economics, and navigating regulatory frameworks in Norway.
Incorporated on February 28, 1994, Legemiddelindustrien (LMI) was established to unify and support Norway’s pharmaceutical sector. Its formation addressed the need for collective representation among companies developing and distributing medicines. This insight aimed to foster innovation and ensure responsible integration into the national healthcare system.
LMI's membership includes major multinational pharmaceutical firms and emerging life science startups across Norway. The association advances medical innovation, driven by a vision to ensure patient access to improved therapies. By promoting research and development, LMI strives for a future where individuals affected by illness achieve enhanced health outcomes.
Key people at Legemiddelindustrien.
Legemiddelindustrien (LMI) is the trade association for the pharmaceutical industry in Norway that represents Norwegian and foreign companies active in development, production, sale or marketing of medicines and related health solutions in Norway[2].
High-Level Overview
Origin Story
Core Differentiators
Role in the Broader Tech / Health Landscape
Quick Take & Future Outlook
Key sources: LMI’s own “Information in English” page and event/materials about market access and member activities provide the primary public description of the organisation and its services[2][6].